UTHR.NASDAQUnited Therapeutics CORP
Form 4: UNITED THERAPEUTICS CEO Sells Shares
Sentiment:
Insider Transaction (Form 4)
Martine A Rothblatt, Chairperson & CEO and a Director of UNITED THERAPEUTICS Corp, sold 9,500 shares of common stock on August 11, 2026.
Summary
- Option exercise/conversion: acquired 9,500 Common Stock at $135.42 ($1,286,490) on August 11, 2026; holds 333,943 after (Indirect).
- Open-market sale: disposed of 475 Common Stock at $513.37 ($243,852) on August 11, 2026; holds 333,468 after (Indirect).
- Open-market sale: disposed of 1,214 Common Stock at $514.52 ($624,633) on August 11, 2026; holds 332,254 after (Indirect).
- Open-market sale: disposed of 360 Common Stock at $515.52 ($185,586) on August 11, 2026; holds 331,894 after (Indirect).
- Open-market sale: disposed of 520 Common Stock at $516.91 ($268,794) on August 11, 2026; holds 331,374 after (Indirect).
- Open-market sale: disposed of 120 Common Stock at $517.57 ($62,108) on August 11, 2026; holds 331,254 after (Indirect).
- Open-market sale: disposed of 120 Common Stock at $518.95 ($62,274) on August 11, 2026; holds 331,134 after (Indirect).
- Open-market sale: disposed of 200 Common Stock at $520.59 ($104,119) on August 11, 2026; holds 330,934 after (Indirect).
- Open-market sale: disposed of 200 Common Stock at $521.73 ($104,347) on August 11, 2026; holds 330,734 after (Indirect).
- Open-market sale: disposed of 221 Common Stock at $523.04 ($115,591) on August 11, 2026; holds 330,513 after (Indirect).
- Open-market sale: disposed of 379 Common Stock at $524.13 ($198,647) on August 11, 2026; holds 330,134 after (Indirect).
- Open-market sale: disposed of 871 Common Stock at $525.19 ($457,442) on August 11, 2026; holds 329,263 after (Indirect).
- Open-market sale: disposed of 2,725 Common Stock at $526.05 ($1,433,481) on August 11, 2026; holds 326,538 after (Indirect).
- Open-market sale: disposed of 935 Common Stock at $527.16 ($492,895) on August 11, 2026; holds 325,603 after (Indirect).
- Open-market sale: disposed of 737 Common Stock at $528.07 ($389,186) on August 11, 2026; holds 324,866 after (Indirect).
- Open-market sale: disposed of 143 Common Stock at $529.05 ($75,654) on August 11, 2026; holds 324,723 after (Indirect).
- Open-market sale: disposed of 280 Common Stock at $531.01 ($148,683) on August 11, 2026; holds 324,443 after (Indirect).
- Option exercise/conversion: disposed of 9,500 Stock Option on August 11, 2026; holds 160,910 after (Indirect).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $4,967,292 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Martine A Rothblatt — Director, Officer (Chairperson & CEO)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-11 | Option exercise/conversion | Common Stock | 9,500 | $135 | $1.3M | 333,943 |
| 2026-08-11 | Open-market sale | Common Stock | 475 | $513 | $243.9K | 333,468 |
| 2026-08-11 | Open-market sale | Common Stock | 1,214 | $515 | $624.6K | 332,254 |
| 2026-08-11 | Open-market sale | Common Stock | 360 | $516 | $185.6K | 331,894 |
| 2026-08-11 | Open-market sale | Common Stock | 520 | $517 | $268.8K | 331,374 |
| 2026-08-11 | Open-market sale | Common Stock | 120 | $518 | $62.1K | 331,254 |
| 2026-08-11 | Open-market sale | Common Stock | 120 | $519 | $62.3K | 331,134 |
| 2026-08-11 | Open-market sale | Common Stock | 200 | $521 | $104.1K | 330,934 |
| 2026-08-11 | Open-market sale | Common Stock | 200 | $522 | $104.3K | 330,734 |
| 2026-08-11 | Open-market sale | Common Stock | 221 | $523 | $115.6K | 330,513 |
| 2026-08-11 | Open-market sale | Common Stock | 379 | $524 | $198.6K | 330,134 |
| 2026-08-11 | Open-market sale | Common Stock | 871 | $525 | $457.4K | 329,263 |
| 2026-08-11 | Open-market sale | Common Stock | 2,725 | $526 | $1.4M | 326,538 |
| 2026-08-11 | Open-market sale | Common Stock | 935 | $527 | $492.9K | 325,603 |
| 2026-08-11 | Open-market sale | Common Stock | 737 | $528 | $389.2K | 324,866 |
| 2026-08-11 | Open-market sale | Common Stock | 143 | $529 | $75.7K | 324,723 |
| 2026-08-11 | Open-market sale | Common Stock | 280 | $531 | $148.7K | 324,443 |
| 2026-08-11 | Option exercise/conversion | Stock Option | 9,500 | — | — | 160,910 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-11 | Option exercise/conversion (9,500 shares) |
| 2026-08-11 | Open-market sale (475 shares) |
| 2026-08-11 | Open-market sale (1,214 shares) |
| 2026-08-11 | Open-market sale (360 shares) |
| 2026-08-11 | Open-market sale (520 shares) |
| 2026-08-11 | Open-market sale (120 shares) |
| 2026-08-11 | Open-market sale (120 shares) |
| 2026-08-11 | Open-market sale (200 shares) |
| 2026-08-11 | Open-market sale (200 shares) |
| 2026-08-11 | Open-market sale (221 shares) |
| 2026-08-11 | Open-market sale (379 shares) |
| 2026-08-11 | Open-market sale (871 shares) |
| 2026-08-11 | Open-market sale (2,725 shares) |
| 2026-08-11 | Open-market sale (935 shares) |
| 2026-08-11 | Open-market sale (737 shares) |
| 2026-08-11 | Open-market sale (143 shares) |
| 2026-08-11 | Open-market sale (280 shares) |
| 2026-08-11 | Option exercise/conversion (9,500 shares) |
Keywords
insider transaction, Form 4, UTHR, UNITED THERAPEUTICS Corp, bearish, Martine A Rothblatt
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.